Use of 1,2-bridged 1,4-dihydropyridines as medicaments

The present invention relates to the new use of 1,2-bridged 1,4-dihydropyridines which are known in some cases, of the general formula (I) in which R1 to R4 and a have the meaning indicated in the description, processes for their preparation and their use as medicaments, as selective potassium chann...

Full description

Saved in:
Bibliographic Details
Main Authors GLASER; THOMAS, URBAHNS; KLAUS, HEINE; HANS-GEORG, WITTKA; REILINDE, DE VRY; JEAN-MARIE-VIKTOR, JUNGE; BODO, SOMMERMEYER; HENNING
Format Patent
LanguageEnglish
Published 23.11.1999
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the new use of 1,2-bridged 1,4-dihydropyridines which are known in some cases, of the general formula (I) in which R1 to R4 and a have the meaning indicated in the description, processes for their preparation and their use as medicaments, as selective potassium channel modulators, in particular for the treatment of the central nervous system.
Bibliography:Application Number: US19950569534